La sociedad impulsada por el Colegio de Médicos de Barcelona se suma al accionariado de la firma, participada mayoritariamente por...Read more
Andres Montefeltro, president and CEO of nLife studied at Hamburg, Austria, the Advanced Business Development Course. This intensive course,...Read more
The 2013 BIO International Convention , the global...Read more
for a Healthy Life
nLife Therapeutics is a biotechnology company leading the discovery and development of oligonucleotides as therapeutic agents for those CNS disorders where unmet medical needs are not covered by traditional treatments.